News

Deal Announcements

Astute Medical Adds $20 Million Venture Financing

Thursday, October 15, 2015 5:46:00 AM PDT | VentureDeal
   San Diego, California  --  Medical device company Astute Medical has landed $20 million in new venture capital equity funding, according to an SEC regulatory filing.

Astute is focused on identifying invalidating protein biomarkers of severe acute disease.

The company is focused on community and hospital acquired acute conditions that require rapid diagnosis and risk assessment.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Astute is still seeking $8 million in additional financing, according to the regulatory filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1